ALS Clinical Trials Review: 20 Years of Failure. Are We Any Closer to Registering a New Treatment?
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ALS Clinical Trials Review: 20 Years of Failure. Are We Any Closer to Registering a New Treatment?
Authors
Keywords
-
Journal
Frontiers in Aging Neuroscience
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-03-22
DOI
10.3389/fnagi.2017.00068
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ALS and FTD: an epigenetic perspective
- (2016) Veronique V. Belzil et al. ACTA NEUROPATHOLOGICA
- ALS: Recent Developments from Genetics Studies
- (2016) Martine Therrien et al. Current Neurology and Neuroscience Reports
- A look into the future of ALS research
- (2016) Pascaline Clerc et al. DRUG DISCOVERY TODAY
- Amyotrophic lateral sclerosis and environmental factors
- (2016) Virginia Bozzoni FUNCTIONAL NEUROLOGY
- Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis
- (2016) Benoît Marin et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Post-paralysis tyrosine kinase inhibition with masitinib abrogates neuroinflammation and slows disease progression in inherited amyotrophic lateral sclerosis
- (2016) Emiliano Trias et al. Journal of Neuroinflammation
- Recent advances in amyotrophic lateral sclerosis
- (2016) Nilo Riva et al. JOURNAL OF NEUROLOGY
- Supportive and symptomatic management of amyotrophic lateral sclerosis
- (2016) Esther V. Hobson et al. Nature Reviews Neurology
- ALS: A bucket of genes, environment, metabolism and unknown ingredients
- (2016) Mónica Zufiría et al. PROGRESS IN NEUROBIOLOGY
- A randomized, placebo-controlled, double-blind phase IIb trial evaluating the safety and efficacy of tirasemtiv in patients with amyotrophic lateral sclerosis
- (2016) Jeremy M. Shefner et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- A retrospective review of the progress in amyotrophic lateral sclerosis drug discovery over the last decade and a look at the latest strategies
- (2015) Abigail DeLoach et al. Expert Opinion on Drug Discovery
- Erythropoietin in amyotrophic lateral sclerosis: a multicentre, randomised, double blind, placebo controlled, phase III study
- (2015) Giuseppe Lauria et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Oxidative Stress in Neurodegenerative Diseases
- (2015) Ewa Niedzielska et al. MOLECULAR NEUROBIOLOGY
- Symptom Management and End-of-Life Care in Amyotrophic Lateral Sclerosis
- (2015) Carlayne E. Jackson et al. NEUROLOGIC CLINICS
- A phase II−III trial of olesoxime in subjects with amyotrophic lateral sclerosis
- (2014) T. Lenglet et al. EUROPEAN JOURNAL OF NEUROLOGY
- The past, present and future of stem cell clinical trials for ALS
- (2014) Gretchen M. Thomsen et al. EXPERIMENTAL NEUROLOGY
- Clinical trials in amyotrophic lateral sclerosis: why so many negative trials and how can trials be improved?
- (2014) Hiroshi Mitsumoto et al. LANCET NEUROLOGY
- Preclinical research: Make mouse studies work
- (2014) Steve Perrin NATURE
- Neuroprotective effect of masitinib in rats with postischemic stroke
- (2014) Ivan Kocic et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- A post hoc analysis of subgroup outcomes and creatinine in the phase III clinical trial (EMPOWER) of dexpramipexole in ALS
- (2014) Michael E. Bozik et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- NP001 regulation of macrophage activation markers in ALS: A phase I clinical and biomarker study
- (2014) Robert G. Miller et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients
- (2014) Koji Abe et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Is SOD1 loss of function involved in amyotrophic lateral sclerosis?
- (2013) Rachele A. Saccon et al. BRAIN
- Oxidative Stress and Neurodegenerative Disorders
- (2013) Jie Li et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Immune-mediated Mechanisms in the Pathoprogression of Amyotrophic Lateral Sclerosis
- (2013) Weihua Zhao et al. Journal of Neuroimmune Pharmacology
- Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial
- (2013) Merit E Cudkowicz et al. LANCET NEUROLOGY
- Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial
- (2013) LANCET NEUROLOGY
- Design and Initial Results of a Multi-Phase Randomized Trial of Ceftriaxone in Amyotrophic Lateral Sclerosis
- (2013) James D. Berry et al. PLoS One
- The relationship between tirasemtiv serum concentration and functional outcomes in patients with ALS
- (2013) Jeremy M. Shefner et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- A study to evaluate safety and tolerability of repeated doses of tirasemtiv in patients with amyotrophic lateral sclerosis
- (2013) Jeremy M. Shefner et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Safety, tolerability and pharmacodynamics of a skeletal muscle activator in amyotrophic lateral sclerosis
- (2012) Jeremy Shefner et al. Amyotrophic Lateral Sclerosis
- Masitinib treatment in patients with progressive multiple sclerosis: a randomized pilot study
- (2012) Patrick Vermersch et al. BMC Neurology
- Lithium lacks effect on survival in amyotrophic lateral sclerosis: a phase IIb randomised sequential trial
- (2012) Esther Verstraete et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- A Randomized, Double Blind, Placebo-Controlled Trial of Pioglitazone in Combination with Riluzole in Amyotrophic Lateral Sclerosis
- (2012) Luc Dupuis et al. PLoS One
- Amyotrophic lateral sclerosis
- (2011) Matthew C Kiernan et al. LANCET
- The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis
- (2011) Merit Cudkowicz et al. NATURE MEDICINE
- Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trial
- (2011) François Piette et al. Alzheimers Research & Therapy
- A randomized, placebo-controlled trial of memantine for functional disability in amyotrophic lateral sclerosis
- (2010) Mamede de Carvalho et al. Amyotrophic Lateral Sclerosis
- A Review of the Neural Mechanisms of Action and Clinical Efficiency of Riluzole in Treating Amyotrophic Lateral Sclerosis: What have we Learned in the Last Decade?
- (2010) Mark C. Bellingham CNS Neuroscience & Therapeutics
- Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial
- (2010) Swati P Aggarwal et al. LANCET NEUROLOGY
- Neurotrophic growth factors for the treatment of amyotrophic lateral sclerosis: where do we stand ?
- (2010) Henriques Frontiers in Neuroscience
- Erythropoietin in amyotrophic lateral sclerosis: A pilot, randomized, double-blind, placebo-controlled study of safety and tolerability
- (2009) Giuseppe Lauria et al. Amyotrophic Lateral Sclerosis
- A phase II trial of talampanel in subjects with amyotrophic lateral sclerosis
- (2009) Robert M. Pascuzzi et al. Amyotrophic Lateral Sclerosis
- Glatiramer acetate has no impact on disease progression in ALS at 40 mg/day: A double- blind, randomized, multicentre, placebo-controlled trial
- (2009) Vincent Meininger et al. Amyotrophic Lateral Sclerosis
- Randomized sequential trial of valproic acid in amyotrophic lateral sclerosis
- (2009) Sanne Piepers et al. ANNALS OF NEUROLOGY
- Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III
- (2009) Petra Kaufmann et al. ANNALS OF NEUROLOGY
- Creatine monohydrate in ALS: Effects on strength, fatigue, respiratory status and ALSFRS
- (2008) Jeffrey Rosenfeld et al. Amyotrophic Lateral Sclerosis
- KNS-760704 [(6R)-4,5,6,7-tetrahydro-N6-propyl-2, 6-benzothiazole-diamine dihydrochloride monohydrate] for the Treatment of Amyotrophic Lateral Sclerosis
- (2008) Valentin K. Gribkoff et al. CNS Neuroscience & Therapeutics
- Subcutaneous IGF-1 is not beneficial in 2-year ALS trial
- (2008) E. J. Sorenson et al. NEUROLOGY
- Creatine and Its Potential Therapeutic Value for Targeting Cellular Energy Impairment in Neurodegenerative Diseases
- (2008) Peter J. Adhihetty et al. NEUROMOLECULAR MEDICINE
- Lithium delays progression of amyotrophic lateral sclerosis
- (2008) F. Fornai et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search